Replies to post #239956 on Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

DesireToLearn, I agree!!!

Looking forward to seeing the dose dependant improving response of P using 2x the dose as P2a study. Twice the dose and easier trial conditions. Also, secondary endpoint analysis should be interesting as the company was aiming to be understand other potential applications of Prurisol.

Good luck and GOD bless,

George